677 related articles for article (PubMed ID: 12231538)
21. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor and basic fibroblast growth factor expression positively correlates with angiogenesis and peritumoural brain oedema in astrocytoma.
Jang FF; Wei W; De WM
J Ayub Med Coll Abbottabad; 2008; 20(2):105-9. PubMed ID: 19385471
[TBL] [Abstract][Full Text] [Related]
23. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
Nagashima M; Asano G; Yoshino S
J Rheumatol; 2000 Oct; 27(10):2339-42. PubMed ID: 11036826
[TBL] [Abstract][Full Text] [Related]
24. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
[TBL] [Abstract][Full Text] [Related]
25. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells.
Hajitou A; Grignet C; Devy L; Berndt S; Blacher S; Deroanne CF; Bajou K; Fong T; Chiang Y; Foidart JM; Noël A
FASEB J; 2002 Nov; 16(13):1802-4. PubMed ID: 12354694
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
[TBL] [Abstract][Full Text] [Related]
27. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
[TBL] [Abstract][Full Text] [Related]
28. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
Bian XW; Jiang XF; Chen JH; Bai JS; Dai C; Wang QL; Lu JY; Zhao W; Xin R; Liu MY; Shi JQ; Wang JM
Int Immunopharmacol; 2006 Jan; 6(1):90-9. PubMed ID: 16332517
[TBL] [Abstract][Full Text] [Related]
29. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients.
Takano S; Yoshii Y; Kondo S; Suzuki H; Maruno T; Shirai S; Nose T
Cancer Res; 1996 May; 56(9):2185-90. PubMed ID: 8616870
[TBL] [Abstract][Full Text] [Related]
30. Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms.
Alvarez JA; Baird A; Tatum A; Daucher J; Chorsky R; Gonzalez AM; Stopa EG
Mod Pathol; 1992 May; 5(3):303-7. PubMed ID: 1495934
[TBL] [Abstract][Full Text] [Related]
31. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
Erdamar S; Bagci P; Oz B; Dirican A
J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
[TBL] [Abstract][Full Text] [Related]
32. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
33. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression.
Takano S; Tsuboi K; Tomono Y; Mitsui Y; Nose T
Br J Cancer; 2000 Jun; 82(12):1967-73. PubMed ID: 10864205
[TBL] [Abstract][Full Text] [Related]
34. Angiostatin suppresses malignant glioma growth in vivo.
Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
[TBL] [Abstract][Full Text] [Related]
35. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
36. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
[TBL] [Abstract][Full Text] [Related]
37. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
[TBL] [Abstract][Full Text] [Related]
38. The role of thrombin in the neo-vascularization of malignant gliomas: an intrinsic modulator for the up-regulation of vascular endothelial growth factor.
Yamahata H; Takeshima H; Kuratsu J; Sarker KP; Tanioka K; Wakimaru N; Nakata M; Kitajima I; Maruyama I
Int J Oncol; 2002 May; 20(5):921-8. PubMed ID: 11956584
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis in malignant gliomas.
Plate KH; Risau W
Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
[TBL] [Abstract][Full Text] [Related]
40. [p53 and vascular endothelial growth factor expression in astrocytoma and their relation to angiogenesis].
Ye S; Zhong X; Chen Y
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):326-9. PubMed ID: 11783119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
